The HMGA2 (high mobility group AT-hook 2) gene is overexpressed in 65% of these types of tumors and mutations in a transcriptional regulator complex subunit 12 (MED12) are demonstrated in 70% of fibroids [3,4]. Here, HMGA2 is linked to leiomyoma.